Michael Howell
Chief Tech/Sci/R&D Officer at ZURA BIO LIMITED
Net worth: 443 023 $ as of 29/04/2024
Michael Howell active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ZURA BIO LIMITED | Chief Tech/Sci/R&D Officer | 13/04/2023 | - |
| Corporate Officer/Principal | 30/11/2022 | 13/04/2023 |
Career history of Michael Howell
Former positions of Michael Howell
| Companies | Position | Start | End |
|---|---|---|---|
| DERMTECH, INC. | Chief Tech/Sci/R&D Officer | 07/09/2020 | 31/10/2022 |
| INCYTE CORPORATION | Corporate Officer/Principal | 30/09/2016 | 31/07/2020 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 30/11/2013 | 31/10/2016 |
Immune Tolerance Network
 Immune Tolerance Network Miscellaneous Commercial ServicesCommercial Services Immune Tolerance Network provides clinical research services. It offers immune tolerance therapies for autoimmune disease, allergies and asthma, organ transplantation, and type 1 diabetes. The company was founded by Jeffrey A. Bluestone in 1999 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 31/05/2012 | 30/11/2013 |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | 31/03/2010 | 31/07/2012 |
Training of Michael Howell
| University of Messiah | Undergraduate Degree |
| West Virginia University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 7 |
| 2 | |
| Germany | 2 |
Operational
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| DERMTECH, INC. | Health Technology |
| INCYTE CORPORATION | Health Technology |
| ZURA BIO LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
Immune Tolerance Network
Immune Tolerance Network Miscellaneous Commercial ServicesCommercial Services Immune Tolerance Network provides clinical research services. It offers immune tolerance therapies for autoimmune disease, allergies and asthma, organ transplantation, and type 1 diabetes. The company was founded by Jeffrey A. Bluestone in 1999 and is headquartered in Seattle, WA. | Commercial Services |
Boehringer Ingelheim GmbH
Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
- Stock Market
- Insiders
- Michael Howell
- Experience
